Fresenius Medical Care Sees US Plans for Kidney Disease as Positive
Browser Upgrade Recommended: Our website has detected that you are using a version of Internet Explorer that will prevent you from accessing certain features on FMCNA.com. We strongly recommend that you use a different browser to optimize your viewing experience. Supported browsers include Chrome, Edge, Firefox, and Safari.
We’re also expanding efforts to include biosensing wearables–such as digital blood pressure monitors and glucose sensors—exploring ways connected health technologies can empower patients to become more active participants in their care.
Q: Do connected health technologies have the potential to affect patient engagement?
JH: Connected Health technologies can improve the way patients interact with and perceive their health care. In fact, patient empowerment and engagement increase when patients are actively involved in managing their own health.
For example, home therapies patients dialyzing at home may not have the same level of caregiver or social interaction as patients who dialyze in-center. A good deal of success for a home dialysis patient relies on their feeling properly supported and secure. The interactivity and connectivity between patient, their providers and care teams increase the patient’s sense of security and reduces their sense of isolation.
Whether it’s using our patient portal, remote patient monitoring devices, using biosensing wearables, or completing doctor visits via telehealth, connected health technologies put patients in charge of their own care by directly connecting them with their care team’s efforts to improve their wellness. With the patients we serve being at the heart of everything we do, connected health technologies enable the type of connectivity required to truly deliver patient-centered care.
In his role as Chief Medical Officer for Fresenius Kidney Care and Senior Vice President for Fresenius Medical Care North America, Jeffrey Hymes, MD, leads quality clinical care across the United States for the company’s nationwide network of dialysis clinics. The Chairman of the Fresenius Kidney Care Pharmacy and Therapeutics Committee, Dr. Hymes co-founded REN Corporation and National Nephrology Associates, formerly serving as NNA’s president and chief medical officer. He completed his medical internship and residency at the Yale New Haven Medical Center, received subspecialty training at Boston University, and is board certified in internal medicine. Dr. Hymes earned his MD degree from the Albert Einstein College of Medicine in New York and is a graduate of Yale College.
Connected Health: Improving Patient Care Through New Technology by Dr. Ahmad Sharif